World's Best Scientists 2026 revealed!
Pieter A. Doevendans

Pieter A. Doevendans

D-Index & Metrics

Medicine

D-Index
123
Citations
56400
World Ranking
3355
National Ranking
124

Pieter A. Doevendans publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pieter A. Doevendans sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 801 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pieter A. Doevendans D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pieter A. Doevendans sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 123 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pieter A. Doevendans is affiliated with Utrecht University in the Netherlands. Their research primarily focuses on medicine, with a substantial body of work in cardiology and cardiovascular medicine.

Their subfields of study include:

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Molecular Biology
  • Biomedical Engineering
  • Radiology, Nuclear Medicine and Imaging

Main topics addressed in their work comprise:

  • Cardiac electrophysiology and arrhythmias
  • ECG Monitoring and Analysis
  • Cardiac Arrhythmias and Treatments
  • Cardiac Valve Diseases and Treatments
  • Cardiomyopathy and Myosin Studies
  • Tissue Engineering and Regenerative Medicine
  • Cardiac pacing and defibrillation studies

Among their frequent co-authors are:

  • Joost P. G. Sluijter (52 publications)
  • René van Es (39 publications)
  • Maarten J. Cramer (24 publications)
  • Rutger R van de Leur (24 publications)
  • Rutger J. Hassink (22 publications)

Doevendans has published extensively in several venues, including:

  • Netherlands Heart Journal (12 publications)
  • European Heart Journal - Digital Health (6 publications)
  • Frontiers in Cardiovascular Medicine (6 publications)
  • European Heart Journal (5 publications)
  • EP Europace (4 publications)

Recent papers authored by colleagues, reflecting the thematic scope relevant to Doevendans' research, include:

  • Wnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived Cardiomyocytes, 2020, Cell Stem Cell
  • Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success, 2020, Frontiers in Immunology
  • Pulmonary Vein Isolation With Single Pulse Irreversible Electroporation, 2020, Circulation Arrhythmia and Electrophysiology
  • Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis, 2020, The Lancet Haematology
  • Automatic Triage of 12-Lead ECGs Using Deep Convolutional Neural Networks, 2020, Journal of the American Heart Association

Best Publications

  • Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study.

    W. Bob Meijboom;Matthijs F.L. Meijs;Joanne D. Schuijf;Maarten J. Cramer

  • Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury

    Fatih Arslan;Ruenn Chai Lai;Ruenn Chai Lai;Mirjam B. Smeets;Lars Akeroyd

  • MicroRNAs in the Human Heart A Clue to Fetal Gene Reprogramming in Heart Failure

    Thomas Thum;Paolo Galuppo;Christian Wolf;Jan Fiedler

  • Regulation and characteristics of vascular smooth muscle cell phenotypic diversity

    S. S. M. Rensen;P. A. F. M. Doevendans;G. J. J. M. van Eys

  • Association between alcohol and cardiovascular disease:Mendelian randomisation analysis based on individual participant data

    Michael V Holmes;Michael V Holmes;Caroline E Dale;Luisa Zuccolo;Richard J Silverwood

  • HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

    Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes

  • Mendelian randomization of blood lipids for coronary heart disease

    Michael V. Holmes;Folkert W. Asselbergs;Tom M. Palmer;Fotios Drenos

  • Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium.

    Leo Timmers;Sai Kiang Lim;Fatih Arslan;Jeffrey S. Armstrong

  • The severe cardiorenal syndrome: 'Guyton revisited'.

    Lennart G. Bongartz;Maarten Jan Cramer;Pieter A. Doevendans;Jaap A. Joles

  • Incidence and predictors of short- and long-term complications in pacemaker therapy: The FOLLOWPACE study

    Erik O. Udo;Nicolaas P.A. Zuithoff;Norbert M. van Hemel;Carel C. de Cock

  • Role of apoptosis in reperfusion injury

    Frank Eefting;Benno Rensing;Jochem Wigman;Willem Jan Pannekoek

  • Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.

    Leo Timmers;José P.S. Henriques;Dominique P.V. de Kleijn;J. Hans DeVries

  • Visualisation of cell death in vivo in patients with acute myocardial infarction.

    L Hofstra;I H Liem;E A Dumont;Hendrikus Boersma

  • Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking

    Arco J Teske;Bart W L De Boeck;Paul G Melman;Gertjan T Sieswerda

  • Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction

    Leo Timmers;Sai Kiang Lim;Imo E. Hoefer;Fatih Arslan

  • Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction.

    Linda W. van Laake;Robert Passier;Jantine Monshouwer-Kloots;Arie J. Verkleij

  • Inhibition of miR-25 improves cardiac contractility in the failing heart

    Christine Wahlquist;Dongtak Jeong;Agustin Rojas-Muñoz;Changwon Kho

  • Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members

    Judith A. Groeneweg;Aditya Bhonsale;Cynthia A. James;Anneline S. te Riele

  • Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody

    Fatih Arslan;Mirjam B. Smeets;Luke A.J. O'Neill;Brian Keogh

  • 40 MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure

    Thomas Thum;Paolo Galuppo;Christian Wolf;Jan Fiedler

Frequent Co-Authors

Joost P.G. Sluijter
Joost P.G. Sluijter Utrecht University
Marie-José Goumans
Marie-José Goumans Leiden University Medical Center
Gerard Pasterkamp
Gerard Pasterkamp Utrecht University
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center
Yolanda van der Graaf
Yolanda van der Graaf Utrecht University
Arthur A.M. Wilde
Arthur A.M. Wilde University of Amsterdam
Tim Leiner
Tim Leiner Utrecht University
Michiel L. Bots
Michiel L. Bots Utrecht University
Diederick E. Grobbee
Diederick E. Grobbee Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a range of related online degrees and career pathways. Many students and professionals are choosing flexible programs that advance their healthcare credentials while accommodating busy schedules.

For registered nurses seeking career growth, there are adn to fnp bridge programs, which allow RNs to quickly progress from an Associate Degree in Nursing to a Family Nurse Practitioner role. Others may be interested in the best online rn to bsn programs without clinical requirements, which provide a path to a Bachelor's of Science in Nursing without the need for additional in-person training.

Beyond nursing, prospective students can consider a bachelor's in nutrition online, which supports careers in health education, public health, and dietary planning. In healthcare leadership, online mha programs are ideal for those pursuing advanced management roles in hospitals and health systems.

These online pathways allow students to tailor their studies to specific healthcare interests while gaining credentials valued by employers nationwide.

Best Scientists Citing Pieter A. Doevendans

Trending Scientists

Recently Published Articles